| scholarly article | Q13442814 |
| P50 | author | Ian Frazer | Q930011 |
| Tony J. Kenna | Q37371728 | ||
| Graham R. Leggatt | Q37839910 | ||
| Raymond J Steptoe | Q59556035 | ||
| P2093 | author name string | Shaun McColl | |
| Iain Comerford | |||
| Salvatore Fiorenza | |||
| P2860 | cites work | Identification and characterization of macrophage inflammatory protein 2 | Q24338941 |
| Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells | Q24530100 | ||
| Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens | Q24644442 | ||
| Adoptive cell transfer: a clinical path to effective cancer immunotherapy | Q24644774 | ||
| Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells | Q24651232 | ||
| The danger model: a renewed sense of self | Q28214633 | ||
| A human memory T cell subset with stem cell-like properties | Q28248395 | ||
| Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells | Q33831940 | ||
| Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen | Q34065735 | ||
| Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients | Q34111120 | ||
| Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. | Q34610483 | ||
| Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice | Q34667739 | ||
| CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis | Q34937677 | ||
| Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice | Q35223241 | ||
| Prevention of cervical cancer through papillomavirus vaccination | Q35620080 | ||
| Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream | Q35632513 | ||
| Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells | Q35638571 | ||
| Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells | Q36072746 | ||
| Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates | Q36183567 | ||
| An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues | Q36228795 | ||
| Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation | Q36229698 | ||
| Chemokines in tumor immunotherapy | Q36251142 | ||
| Adoptive cell therapy for the treatment of patients with metastatic melanoma | Q36283034 | ||
| Migratory properties of naive, effector, and memory CD8(+) T cells | Q36369485 | ||
| Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues | Q36402630 | ||
| Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice | Q36844160 | ||
| Overcoming obstacles to the effective immunotherapy of human cancer | Q36861601 | ||
| T cell tolerance to tumors and cancer immunotherapy | Q36916298 | ||
| Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells | Q36916400 | ||
| Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours? | Q37216809 | ||
| High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction | Q37355703 | ||
| Monocyte chemoattractant protein-1 (MCP-1): an overview | Q37481208 | ||
| Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin | Q39705893 | ||
| Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells | Q39878879 | ||
| Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists | Q39980549 | ||
| Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival | Q40325046 | ||
| TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance | Q40351779 | ||
| CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow | Q42479557 | ||
| Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment | Q42512982 | ||
| Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study | Q43202683 | ||
| Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy | Q43705031 | ||
| Targeting antigen to diverse APCs inactivates memory CD8+ T cells without eliciting tissue-destructive effector function | Q44234403 | ||
| Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones. | Q45953850 | ||
| Changes to peptide structure, not concentration, contribute to expansion of the lowest avidity cytotoxic T lymphocytes | Q47231150 | ||
| CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction | Q47644730 | ||
| Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy". | Q47819013 | ||
| Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. | Q51807372 | ||
| Antigen-specific CD4 cells assist CD8 T-effector cells in eliminating keratinocytes. | Q51887160 | ||
| Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia. | Q51956884 | ||
| Selective stimulation of T cell subsets with antibody-cytokine immune complexes. | Q51984700 | ||
| Testing time-, ignorance-, and danger-based models of tolerance. | Q52021172 | ||
| Making and circumventing tolerance to cancer. | Q52909563 | ||
| Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. | Q53391760 | ||
| Cognate CD4+ help elicited by resting dendritic cells does not impair the induction of peripheral tolerance in CD8+ T cells. | Q53573163 | ||
| Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors | Q56959455 | ||
| Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes | Q57174480 | ||
| Cutting Edge: Enhanced IL-2 Signaling Can Convert Self-Specific T Cell Response from Tolerance to Autoimmunity | Q57227367 | ||
| Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses | Q57667259 | ||
| Skin Inflammation Is Not Sufficient to Break Tolerance Induced against a Novel Antigen | Q61715982 | ||
| Invariant NKT Cells in Hyperplastic Skin Induce a Local Immune Suppressive Environment by IFN- Production | Q62230162 | ||
| A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes | Q68804520 | ||
| Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2 | Q70224204 | ||
| Vigorous allograft rejection in the absence of danger | Q73520550 | ||
| Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure | Q77198563 | ||
| TLR7 stimulation augments T effector-mediated rejection of skin expressing neo-self antigen in keratinocytes | Q80404457 | ||
| Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection | Q81022613 | ||
| IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host | Q84080110 | ||
| Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells | Q84624928 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 5622-5631 | |
| P577 | publication date | 2012-11-09 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin | |
| P478 | volume | 189 |
| Q35005565 | Alocasia cucullata exhibits strong antitumor effect in vivo by activating antitumor immunity |
| Q35151883 | Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment |
| Q36307642 | Controlled release strategies for modulating immune responses to promote tissue regeneration |
| Q37612747 | Effector and central memory T helper 2 cells respond differently to peptide immunotherapy |
| Q36871188 | Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice |
| Q34395881 | HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells |
| Q42265908 | Impact of T cell selection methods in the success of clinical adoptive immunotherapy |
| Q38802594 | Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells |
| Q38271879 | Modes of action of TLR7 agonists in cancer therapy |
| Q36223307 | Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection |
Search more.